Cycling biologic therapy with tezepelumab and mepolizumab for eosinophilic otitis media and eosinophilic pneumonia in a patient with asthma
{{output}}
Sequential use of biologic therapies such as tezepelumab and mepolizumab may represent a steroid-sparing and effective treatment approach for managing distinct eosinophilic disorders, including eosinophilic pneumonia and eosinophilic otitis media, which may re... ...
